11.08.2016 • News

Philippe Saudan Chief Development Officer at Kuros

Kuros Biosciences has appointed Dr. Philippe Saudan as chief development officer and member of the executive board with immediate effect. With a PhD in biology
from the University of Lausanne, Switzerland, and a 16 year-career in the pharmaceutical industry, Saudan has held management roles in R&D and last served as Chief Scientific Officer of Cytos Biotechnology. Since February 2016, he has been working as Head of Integration at Kuros.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.